Oncology Insights 2024 Grant Program Official Rules

NO PURCHASE OR PAYMENT OF ANY KIND IS NECESSARY TO ENTER OR WIN

ELIGIBILITY
Participation in the GENEWIZ Oncology Insights 2024 Grant Program is open to individuals professionally engaged in laboratory-based scientific research and have attained at least the age of majority in their jurisdiction of residence (entrants must, in any event, be at least 18 years of age). Employees, officers, directors, agents, representatives and independent contractors of the Sponsors, its subsidiaries, or affiliated companies, together with their immediate family members and members of the same households (whether related or not) are not eligible to participate. Also ineligible are (1) residents of Cuba, Iran, North Korea, Syria, the Crimea region of Ukraine, Russia, or any country subject to U.S. embargo; (2) any persons (including businesses, research institutions, government and private organizations, individuals, and other types of legal persons) on the U.S. government’s Denied Persons List, Specially Designated Nationals list, Entity List, Unverified List or any other similar list maintained by the U.S. government or any other government to whose laws the Sponsors, its subsidiaries or affiliated companies, the Grant Program or such person is subject, and all individuals employed thereby or otherwise associated therewith; and (3) any persons for whom it would be illegal to participate in or win the Grant Program, or with or to whom it would be illegal for the Sponsors to interact or award the prize as contemplated herein. The Grant Program is subject to all applicable laws and regulations, and is void where prohibited or where registration, bonding or language translation is required.

HOW TO ENTER
The GENEWIZ Oncology Insights 2024 Grant Program begins on April 1, 2024 at 12:01 a.m. (ET) and ends on May 24, 2024 at 11:59 p.m. (ET). The contest is open to researchers who have not been the winner for another Azenta Life Sciences grant program in the past year. To enter, participants must submit an online application to the Grant Program via web.genewiz.com/oncology-insights-event/grants. Applications become the property of the Sponsors. The Sponsors make no guarantee or warranty concerning the security or confidentiality of applications or the application process. By entering, the participant gives permission to the Sponsors to contact the participant regarding the Sponsors’ products and services, whether or not the participant is chosen as the winner. In the event that the Sponsors deem a participant to have made multiple applications to enter or to have acted in bad faith with respect to the Grant Program, the participant shall be excluded from the Grant Program and consequently ineligible to win the prize, as defined below.

SELECTION OF WINNER AND NOTIFICATION
Winners will be selected from all qualified applications by a panel of the Sponsors’ scientists, who will choose the grant application that best makes use of the prize. Entrants are not eligible to win multiple prizes in the Grant Program. The decision of this panel will be final and binding. The selected winners will be attempted to be notified by email within approximately five (5) business days after selection. If the selected winner has not responded to email inquiries within three (3) days, the Sponsors will attempt to contact the winner by telephone. If the winner cannot be reached by telephone within forty-eight (48) hours of the first telephone attempt to notify such winner, the prize may be forfeited and an alternate winner may be selected, based on the criteria set forth above, at the Sponsors’ discretion. The odds of winning depend on the number of eligible entries received.

PRIZE DESCRIPTION & CONSUMER DISCLOSURE
One award consists of a $5,000 value (or its local currency equivalent) toward a single order towards a GENEWIZ Gene Synthesis oncology application (no assay type restrictions). A second award consists of a $10,000 credit (or its local currency equivalent) toward a single order using the newly introduced GENEWIZ Precision Antibody Discovery (PAD) service. A third award of $5,000 (or its local currency equivalent) is to be allocated towards a single order using GENEWIZ Next Generation Sequencing in an oncology-related application. The fourth and final award of $5,000 (or its local currency equivalent) is to be used for a single order using GENEWIZ Olink Proteomics® services offered through GENEWIZ from Azenta Life Sciences. All awarded amounts will be made available in the form of an account credit. Any unused credit will be forfeited and cannot be transferred to another project.

RESTRICTIONS APPLY
Orders using the credit must be confirmed by September 30, 2024. If starting material is to be provided, it must be received by September 30, 2024 and meet our sample submission guidelines as indicated in the quote or as outlined on www.genewiz.com/Public/Resources/Sample-Submission-Guidelines. The credit cannot be combined with other discounts, offers, or promotions. The Sponsors may refuse to award the prize or modify any terms if the winner attempts to redeem the credit on an order that varies significantly from the proposed project in the grant application or if the list price of the order is less than the prize. For next generation sequencing projects, the preferred service package, where appropriate, may be used for calculating the list price of the project. Awarded grant funds for NGS cannot be applied to the following services: next generation sequencing only, next generation EZ services, next generation custom projects, or next generation projects already confirmed as determined by project management consultation. GENEWIZ synthesis solutions funded grants can only be applied towards recombinant antibody production, AAV Packaging, Lentivirus packaging, custom mRNA synthesis or gene synthesis services. The award may not be transferred or assigned; no substitutions or cash equivalents are allowed. The winner may be required to execute and return an affidavit of eligibility/release of liability/publicity release (where legal) within twenty-one (21) days of notification attempt. If the winner fails to return the affidavit/release by the deadline, the award will be forfeited and an alternate winner may be selected, based on the criteria set forth above, at the Sponsors’ discretion. The participant understands and agrees that no ideas, information or materials that are submitted to or otherwise provided to the Sponsors in connection with the Grant Program will be returned, and that the Sponsors make no guarantee or warranty with respect to the security or confidentiality thereof. All taxes on the prize and reporting thereof, and any other costs, fees and expenses relating to the prize or the Grant Program, are the sole responsibility of the winner and/or the winner’s institution or company. By submitting an application or accepting the prize, the participant agrees on behalf of the participant and the participant’s institution or company: (1) to be bound by these official rules; (2) that the Sponsors shall retain full authority, in their sole discretion, to interpret and administer these rules; (3) that any dispute with regard to the conduct of the Grant Program, rule interpretation or award of the prize, shall be resolved by the Sponsors, whose decision shall be binding and final; and (4) to be bound by all decisions and interpretations made in good faith by the Sponsors. Furthermore, the participant represents and warrants that: (1) the participant meets the eligibility requirements of the Grant Program; (2) the participant has obtained all required authorizations and permissions from the participant’s institution or company; (3) entering into the Grant Program does not and will not violate any law or regulation, or any of the institution’s or company’s rules or policies; and (4) the information contained in the application is true and correct in all material respects and is owned or rightfully possessed by the participant without restriction on disclosure. The Sponsors may refuse to award the prize if the Sponsors determine in their sole discretion that doing so would likely result in a violation of an applicable law, rule, or policy. Grant winner samples should not be pathogenic.

USE OF WINNER'S NAME
The participant acknowledges and agrees that, if the participant is selected as the winner, the participant’s name, biographical information, likeness, the name of the participant’s institution or company and the project title (excluding further project details) may, without further compensation, be published on one or more Sponsor website(s) and, at the Sponsors’ discretion, through social media. By accepting the prize, the winner grants to the Sponsors, on behalf of the winner and the winner’s institution or company, the right, at any time and from time to time, to print, publish, broadcast and use, worldwide and in any media now known or hereafter developed (including, but not limited to, social media, the Internet and the world wide web), the winning participant’s name, biographical information, (if provided by the participant) image, likeness, the name of the winning participant’s institution or company and the project title (excluding further project details).

INDEMNITY, DISCLAIMER, & LIMITATION OF LIABILITY
By participating in the Grant Program, the participant agrees on behalf of the participant and the participant’s institution or company to release, discharge, indemnify and hold harmless the Sponsors and their respective affiliates, subsidiaries, officers, directors, employees, agents and representatives from all liability for any injury, loss or damage, including death or property damage, due in whole or part, directly or indirectly, to the participation in the Grant Program or the acceptance, possession, use or misuse of the prize. The Sponsors have not made any warranty, representation, or guarantee, express or implied, in fact or in law, with respect to the prize, including, without limitation, to such prize’s quality or fitness for a particular purpose. THE SPONSORS ARE NOT RESPONSIBLE FOR LOST, LATE, STOLEN, INCOMPLETE, ILLEGIBLE, INACCURATE, UNDELIVERED, DELAYED OR MISDIRECTED ENTRIES, OR FOR ANY COMPUTER, INTERNET, EMAIL, TELEPHONE OR TECHNICAL MALFUNCTIONS OR DELAYS, OR FOR ANY HUMAN ERRORS THAT OCCUR IN THE PROCESSING, TRANSMISSION OR RECEIPT OF ENTRIES, OR FOR INACCURATE TRANSCRIPTION OF ENTRY INFORMATION, OR IF THE GRANT PROGRAM IS NOT CAPABLE OF BEING CONDUCTED AS PLANNED, INCLUDING BUT NOT LIMITED TO INFECTION BY COMPUTER VIRUSES, BUGS, TAMPERING, UNAUTHORIZED INTERVENTION, FRAUD, TECHNICAL FAILURES, OR OTHER CAUSES BEYOND THE CONTROL OF THE SPONSORS. IN NO EVENT SHALL THE SPONSORS OR THEIR RESPECTIVE AFFILIATES, SUBSIDIARIES, OFFICERS, DIRECTORS, EMPLOYEES, AGENTS OR REPRESENTATIVES BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, EXEMPLARY OR PUNITIVE DAMAGES WHATSOEVER ARISING OUT OF OR IN CONJUNCTION WITH PARTICIPATION IN THE GRANT PROGRAM OR THE ACCEPTANCE, POSSESSION, USE OR MISUSE OF THE PRIZE, WHETHER BASED ON WARRANTY, CONTRACT, TORT, STRICT LIABILITY, OR ANY OTHER LEGAL THEORY, AND WHETHER OR NOT ANY OF THEM ARE ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THE FOREGOING LIMITATION OF LIABILITY SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY LAW. THE SPONSORS’ TOTAL AND CUMULATIVE LIABILITY ARISING OUT OF OR IN CONNECTION WITH THE GRANT PROGRAM SHALL IN NO EVENT EXCEED THE TOTAL VALUE OF THE PRIZE.

MISCELLANEOUS
The Sponsors reserve the right to suspend, modify, cancel or terminate the Grant Program without advance notice, including, without limitation, in the event of any act, occurrence or reason that it believes would compromise the legality, integrity, administration or fairness of the Grant Program. If one or more provisions of these official rules are held to be invalid or unenforceable by a court of competent jurisdiction, the remaining provisions shall be valid and enforceable. These official rules are governed by and shall be construed by the laws of the State of New Jersey, USA, without application of its choice of law principles. Should there be a conflict between the laws of the State of New Jersey and any other laws, the conflict will be resolved in favor of the laws of the State of New Jersey. Any dispute that may arise hereunder shall be brought solely in the appropriate state or federal courts sitting in Middlesex County, New Jersey, USA and participant consents to the personal jurisdiction and venue thereof. The failure of the Sponsors to comply with any provision of these official rules due to civil unrest, threat of or actual acts of terrorism or war, embargoes, governmental actions, acts of God, earthquakes, floods, storms, fires, supplier delay, accidents, explosions, epidemics, quarantine restrictions, or other such contingencies beyond the control of the Sponsors, shall not be considered a breach of these rules.

SPONSORS

GENEWIZ from Azenta Life Sciences, 115 Corporate Boulevard, South Plainfield, NJ 07080, USA.